Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management

1:01:00
 
Share
 

Manage episode 243297556 series 1143960
By CureTalks. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have pronounced drug resistance and are believed to be the root cause of failure of many myeloma management therapies. We are talking to Dr William Matsui of Johns Hopkins University School of Medicine to learn about the latest research on multiple myeloma stem cells and their role in novel drug development to treat multiple myeloma.

171 episodes